| HDB has
the capacity to screen up to ten thousand data points
per day in both 96- and 384-well plate formats. Screens
can be performed using our collection of natural compounds
or compounds provided by our customers. HDB will also
provide solutions for the transition from assay to
screening and will help you in assay and screening
validation. |
|
| The
screening services include: |
|
|
 |
Screening
leads for our customers |
|
Secondary screening |
|
SAR (structure activity
relationship) research |
|
Hit-to-optimized
lead solution, the rank of potency |
|
Compound profiling |
|
Dose-response EC50/IC50
determination |
|
| Screening can be
based on either HDB supplied assays or assays transferred
from clients. |
|
| HDB provides
our customers and partners with a fast way to perform
HTS at a low cost. We are the logical solution for
your HTS outsourcing. Our expertise and experience
will ensure smooth communications between our project
team and our partners and customers. |
|
| HDB has
successfully entered into several contract research
agreements with leading pharmaceutical and biotech
companies from both China and abroad. |
|
| Some
of the advantages of using our platform for high-throughput
screening are: |
|
|
|
Rapid data turnaround |
|
Flexible assay formats |
|
High quality data that the industry has come to expect |
|
Interim electronic report, final report in paper and
electronic format |
|
Competitive
prices |
|
| Turnaround time depends
on study size and is normally less than thirty working
days from the reception of compounds. |
|
| We continuously add
new receptors to our functional assay list, so please
contact us directly if you do not see your receptor
of interest. For a detailed quote or more information
on our High Throughput Screening service, please contact
us at operation@hdbiosciences.com |
